Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management

Abstract Beta-adrenergic receptor blockers are used in patients with coronary artery disease (CAD) to reduce the harmful effects of excessive adrenergic activation on the heart. However, there is limited evidence regarding the benefit of beta-blockers in the context of contemporary management follow...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pil Hyung Lee, Gyung-Min Park, Seungbong Han, Yong-Giun Kim, Jong-Young Lee, Jae-Hyung Roh, Jae-Hwan Lee, Young-Hak Kim, Seung-Whan Lee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5bd891b9d5694652b995f08a89f433cb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!